Show Summary Details
Page of

HIV-1 and Meth 

HIV-1 and Meth
HIV-1 and Meth

Howard S. Fox

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 07 July 2020

The stimulant dextro (D)-Methamphetamine hydrochloride (methamphetamine, Meth) is a member of the amphetamine family of abused drugs. Meth is chemically related to amphetamine (dextroamphetamine), with the additional methyl group giving it enhanced lipophilicity, which increases its ability to cross the blood-brain barrier. Significant demographic overlap exists between those who use Meth and those at risk for HIV infection. Several research groups have studied the interaction of Meth and HIV in humans. HIV and Meth appear to have adverse, additive effects on frontal and striatal neuronal and glial markers; and rates of neurocognitive impairment appear to be higher in HIV-positive individuals who use Meth vs. those who do not. This chapter presents the result of clinical trials, non-human primate studies, and non-primate animal studies relevant to interactions between Meth use and HIV. The chapter also discusses Meth toxicity, the effects of Meth on central nervous system function, and interactions among aging, chronic HIV infection, and Meth use.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.